Molina Healthcare director granted 405 shares

GROHOWSKI LEO P reported acquisition or exercise transactions in this Form 4 filing.

Rhea-AI Filing Summary

GROHOWSKI LEO P reported acquisition or exercise transactions in this Form 4 filing.

Molina Healthcare director Leo P. Grohowski received a grant of 405 shares of common stock on April 1, 2026. The award was made under Molina Healthcare’s 2025 Equity Incentive Plan as part of his compensation for board service.

The filing states that directors receive an annual equity award valued at $220,000, with one quarter, or $55,000, granted on the first day of each quarter based on the closing share price. The closing price on April 1, 2026 was $135.82, resulting in the 405-share grant. Following this award, Grohowski directly holds 1,305 shares of Molina Healthcare common stock.

Insider Trade Summary

Grant/Award: 405 shares

Grant/Award 1 txn

Insider GROHOWSKI LEO P

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	405	$135.82	$55K

Holdings After Transaction: Common Stock — 1,305 shares (Direct)

Footnotes (3)

1. F1. Grant of stock under the Issuer's 2025 Equity Incentive Plan in connection with the Reporting Person's services as a Director.
2. F2. The aggregate dollar value of the annual equity award to each director was set at $220,000, with one quarter, or $55,000, to be granted on the first day of each quarter, based on the closing price of the Issuer's common stock on such day. The closing price of the Issuer's common stock on April 1, 2026 was $135.82, which resulted in a grant of 405 shares.
3. F3. Represents the closing price of the Issuer's common stock on April 1, 2026.

Key Figures

Quarterly equity award value: $55,000 Annual director equity award: $220,000 Shares granted: 405 shares +2 more

5 metrics

Quarterly equity award value $55,000 One-quarter of annual director equity award

Annual director equity award $220,000 Equity compensation per Molina Healthcare director

Shares granted 405 shares Equity grant to director Leo P. Grohowski on April 1, 2026

Grant price $135.82 per share Closing price of Molina Healthcare common stock on April 1, 2026

Shares held after transaction 1,305 shares Grohowski’s direct holdings after the April 1, 2026 grant

Key Terms

2025 Equity Incentive Plan, annual equity award, closing price

3 terms

2025 Equity Incentive Plan financial

"Grant of stock under the Issuer's 2025 Equity Incentive Plan in connection with the Reporting Person's services as a Director."

annual equity award financial

"The aggregate dollar value of the annual equity award to each director was set at $220,000, with one quarter, or $55,000, to be granted..."

closing price financial

"The closing price of the Issuer's common stock on April 1, 2026 was $135.82, which resulted in a grant of 405 shares."

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did Molina Healthcare (MOH) report for director Leo P. Grohowski?

Molina Healthcare reported that director Leo P. Grohowski received 405 shares of common stock as an equity grant. The grant was issued on April 1, 2026 under the company’s 2025 Equity Incentive Plan as part of his compensation for board service.

How was the 405-share stock grant to Molina Healthcare (MOH) director Grohowski calculated?

The 405-share grant equals one-quarter of a $220,000 annual equity award, or $55,000 per quarter. It was determined using Molina Healthcare’s April 1, 2026 closing stock price of $135.82, which, when divided into $55,000, produced the 405-share award amount.

What is the total annual equity award for Molina Healthcare (MOH) directors?

Each Molina Healthcare director’s annual equity award is set at $220,000, according to the filing footnotes. One quarter of this, or $55,000, is granted on the first day of each quarter, based on the company’s common stock closing price on that day.

What is Leo P. Grohowski’s shareholding in Molina Healthcare (MOH) after the latest grant?

After receiving the 405-share equity grant, Leo P. Grohowski directly holds 1,305 shares of Molina Healthcare common stock. This total reflects his updated position as reported in the Form 4, which includes the new award under the 2025 Equity Incentive Plan.

Under which plan was the Molina Healthcare (MOH) stock granted to director Grohowski?

The 405 shares of Molina Healthcare common stock granted to director Leo P. Grohowski were issued under the company’s 2025 Equity Incentive Plan. The grant represents a scheduled quarterly portion of his annual equity compensation for serving on the board.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 04/02/2026 - 04:49 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

GROHOWSKI LEO P

(Last) (First) (Middle)

200 OCEANGATE

SUITE 100

(Street)

LONG BEACH CALIFORNIA 90802

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
MOLINA HEALTHCARE, INC. [ MOH ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
04/01/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	04/01/2026		A(1)		405(2)	A	$135.82(3)	1,305	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Grant of stock under the Issuer's 2025 Equity Incentive Plan in connection with the Reporting Person's services as a Director.

2. The aggregate dollar value of the annual equity award to each director was set at $220,000, with one quarter, or $55,000, to be granted on the first day of each quarter, based on the closing price of the Issuer's common stock on such day. The closing price of the Issuer's common stock on April 1, 2026 was $135.82, which resulted in a grant of 405 shares.

3. Represents the closing price of the Issuer's common stock on April 1, 2026.

Remarks:

	Jeff D. Barlow, power of attorney for Leo Grohowski	04/02/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)